Total Payments
$2,311
2024 Payments
$995.68
Companies
23
Transactions
93
Medicare Patients
6,414
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$2,311 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,311 | 93 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $376.13 | 16 | $0 (2024) |
| Lilly USA, LLC | $355.41 | 17 | $0 (2024) |
| Dermavant Sciences, Inc. | $258.44 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $164.61 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $139.09 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $106.50 | 1 | $0 (2024) |
| Incyte Corporation | $92.31 | 5 | $0 (2024) |
| LEO Pharma Inc. | $88.12 | 4 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $84.20 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $995.68 | 39 | ABBVIE INC. ($168.45) |
| 2023 | $554.78 | 24 | Dermavant Sciences, Inc. ($123.70) |
| 2022 | $397.09 | 12 | Janssen Scientific Affairs, LLC ($125.00) |
| 2021 | $83.76 | 4 | Lilly USA, LLC ($50.32) |
| 2020 | $33.62 | 2 | Sun Pharmaceutical Industries Inc. ($18.75) |
| 2019 | $35.80 | 2 | Medline Industries, Inc. ($21.05) |
| 2018 | $145.27 | 5 | Merck Sharp & Dohme Corporation ($74.78) |
| 2017 | $65.13 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($41.67) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Dermatology | ||||||
| 10/14/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Dermatology | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 07/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.75 | General |
| 06/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Immunology | ||||||
| 06/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $134.74 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,797 | 2,304 | $1.8M | $616,053 |
| 2022 | 17 | 1,500 | 2,031 | $1.4M | $466,840 |
| 2021 | 20 | 2,039 | 2,720 | $1.8M | $615,370 |
| 2020 | 21 | 1,078 | 1,327 | $762,103 | $304,749 |
Total Patients
6,414
Total Services
8,382
Medicare Billing
$2.0M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 495 | 600 | $778,758 | $298,552 | 38.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 232 | 316 | $248,108 | $97,608 | 39.3% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 149 | 180 | $219,022 | $84,045 | 38.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 245 | 274 | $248,815 | $49,701 | 20.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 120 | 133 | $108,634 | $22,671 | 20.9% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 51 | 67 | $50,360 | $19,798 | 39.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 33 | 34 | $19,799 | $7,357 | 37.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 40 | 40 | $30,529 | $7,188 | 23.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 147 | 171 | $18,556 | $6,960 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 94 | $16,379 | $5,898 | 36.0% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 27 | 27 | $25,849 | $5,097 | 19.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 65 | 87 | $11,176 | $2,880 | 25.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 27 | $9,249 | $2,695 | 29.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 14 | $7,516 | $1,407 | 18.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $6,577 | $1,385 | 21.1% |
| 29580 | Strapping, unna boot | Office | 2023 | 16 | 31 | $3,740 | $1,055 | 28.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 29 | 163 | $2,053 | $769.11 | 37.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 12 | $2,318 | $642.75 | 27.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 20 | $876.40 | $344.40 | 39.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 333 | 392 | $505,237 | $196,341 | 38.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 192 | 253 | $195,761 | $79,063 | 40.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 130 | 154 | $186,215 | $72,113 | 38.7% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 165 | 191 | $177,186 | $36,917 | 20.8% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2022 | 65 | 79 | $58,679 | $23,710 | 40.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 118 | 134 | $111,755 | $23,591 | 21.1% |
About Dr. Patrick Killian, M.D
Dr. Patrick Killian, M.D is a MOHS-Micrographic Surgery healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982663324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Killian, M.D has received a total of $2,311 in payments from pharmaceutical and medical device companies, with $995.68 received in 2024. These payments were reported across 93 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,311).
As a Medicare-enrolled provider, Killian has provided services to 6,414 Medicare beneficiaries, totaling 8,382 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Westlake, OH
- Active Since 03/23/2006
- Last Updated 11/24/2025
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1982663324
Products in Payments
- TALTZ (Drug) $271.02
- VTAMA (Drug) $258.44
- RINVOQ (Biological) $206.11
- DUPIXENT (Biological) $205.93
- TREMFYA (Drug) $205.61
- SKYRIZI (Biological) $155.27
- Sotyktu (Drug) $106.50
- OPZELURA (Drug) $92.31
- Finacea (Drug) $78.94
- KEYTRUDA (Biological) $74.78
- ILUMYA (Biological) $70.12
- ADBRY (Biological) $69.23
- SPEVIGO (Drug) $69.21
- REMICADE (Biological) $58.48
- COSENTYX (Drug) $54.12
- OLUMIANT (Drug) $42.52
- EBGLYSS (Drug) $41.87
- Otezla (Drug) $34.69
- Santyl (Drug) $23.46
- Xolair (Biological) $22.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.